tradingkey.logo
tradingkey.logo
Search

Icecure Medical Ltd

ICCM
Add to Watchlist
3.080USD
0.0000.00%
Close 08-07 16:00ETQuotes delayed by 15 min
225.22MMarket Cap
LossP/E TTM

ICCM Cash Flow Statement

You can access the annual and quarterly cash flow statements of Icecure Medical Ltd to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q2
FY2021Q1
FY2020H1
FY2019H2
FY2019H1
FY2017Q4
FY2017Q3
FY2017H2
FY2017H1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-5.74%-4.27M
-19.64%-5.02M
14.21%-2.71M
-18.96%-2.81M
-41.62%-4.04M
-82.07%-4.20M
5.54%-3.15M
40.49%-2.36M
2.89%-2.85M
44.19%-2.30M
-0.57%-3.34M
-4.91%-3.97M
4.02%-2.94M
---4.13M
---3.32M
-120.31%-3.79M
-66.03%-3.06M
---1.72M
---1.84M
64.06%-722.59K
--354.45K
---2.01M
3.58%-737.71K
-16.29%-625.31K
---1.36M
---1.18M
---765.14K
---537.72K
---955.75K
---879.37K
Net income from continuing operations
-19.12%-4.27M
5.20%-4.25M
6.99%-3.86M
-9.19%-3.36M
0.58%-3.59M
-49.55%-4.48M
-3.72%-4.15M
20.78%-3.08M
4.22%-3.61M
24.22%-3.00M
1.43%-4.00M
13.98%-3.89M
15.27%-3.77M
---3.95M
---4.06M
-82.59%-4.52M
-224.36%-4.45M
---2.48M
---1.37M
29.28%-1.72M
---2.20M
---2.44M
----
----
---1.47M
---1.31M
---768.53K
---576.90K
---828.97K
---1.10M
Operating gains losses
-22.47%69.00K
-13.41%71.00K
-12.05%73.00K
-24.39%62.00K
4.71%89.00K
-1.20%82.00K
1.22%83.00K
3.80%82.00K
7.59%85.00K
12.16%83.00K
17.14%82.00K
51.92%79.00K
51.92%79.00K
--74.00K
--70.00K
92.59%52.00K
126.09%52.00K
--27.00K
--23.00K
70.75%101.92K
--91.82K
--59.69K
----
----
--11.89K
--20.21K
--12.80K
--12.88K
--14.17K
--14.35K
Other non-cash items
-109.52%-4.00K
-3400.00%-198.00K
395.65%136.00K
-361.11%-94.00K
-2.33%42.00K
102.62%6.00K
-143.40%-46.00K
-60.00%36.00K
437.50%43.00K
-94.07%-229.00K
224.71%106.00K
-82.00%90.00K
-87.10%8.00K
---118.00K
---85.00K
558.72%500.00K
-69.90%62.00K
---109.00K
--206.00K
79.89%184.43K
---161.97K
--102.52K
-1694.94%-737.71K
-2033.42%-625.31K
---6.79K
--84.13K
--46.25K
--32.34K
--33.60K
--44.85K
Change in working capital
65.77%-242.00K
-3886.96%-917.00K
-79.18%148.00K
-8.58%405.00K
-284.11%-707.00K
-111.86%-23.00K
338.89%711.00K
300.45%443.00K
-1.03%384.00K
130.12%194.00K
-43.36%162.00K
11.95%-221.00K
-52.86%388.00K
---644.00K
--286.00K
-133.33%-251.00K
203.13%823.00K
--753.00K
---798.00K
538.73%589.55K
--2.44M
--92.30K
----
----
--52.93K
---31.69K
---100.61K
--73.36K
---194.77K
--131.74K
-Change in receivables
172.15%57.00K
-180.25%-227.00K
-90.27%18.00K
205.95%178.00K
-46.30%-79.00K
-1720.00%-81.00K
1750.00%185.00K
-772.00%-168.00K
16.92%-54.00K
-95.76%5.00K
183.33%10.00K
-90.46%25.00K
-750.00%-65.00K
--118.00K
---12.00K
67.95%262.00K
106.41%10.00K
--156.00K
---156.00K
-692.47%-352.02K
--35.36K
--59.41K
----
----
--78.98K
---75.39K
--28.22K
--78.36K
---70.61K
---38.96K
-Change in inventory
56.25%-21.00K
1328.57%86.00K
-3083.33%-382.00K
-306.34%-293.00K
-129.27%-48.00K
-101.89%-7.00K
-111.43%-12.00K
-19.77%142.00K
330.99%164.00K
333.33%371.00K
323.40%105.00K
154.13%177.00K
80.76%-71.00K
---159.00K
---47.00K
-23.86%-327.00K
-169.34%-369.00K
---264.00K
---137.00K
-3082.53%-379.14K
---19.96K
--12.71K
----
----
--13.87K
--37.15K
---21.43K
--7.63K
--11.81K
--9.48K
-Change in prepaid expenses
-301.19%-337.00K
119.35%84.00K
1196.30%350.00K
-202.54%-121.00K
-261.54%-84.00K
-367.90%-434.00K
108.52%27.00K
-57.40%118.00K
-86.10%52.00K
125.19%162.00K
-178.08%-317.00K
-50.45%277.00K
-48.63%374.00K
---643.00K
--406.00K
9216.67%559.00K
767.89%728.00K
--6.00K
---109.00K
50.59%-6.28K
--3.14K
---12.71K
----
----
--2.26K
---5.46K
--2.35K
--0.00
--9.45K
--0.00
-Change in payables and accrued expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
1188.64%1.08M
--2.35M
---99.21K
----
----
---1.98K
---77.57K
---74.21K
--68.89K
---122.85K
--147.12K
-Change in other current assets
-13.86%87.00K
10.14%76.00K
16.42%78.00K
20.00%72.00K
34.67%101.00K
7.81%69.00K
19.64%67.00K
328.57%60.00K
56.25%75.00K
-21.95%64.00K
-17.65%56.00K
-78.79%14.00K
65.52%48.00K
--82.00K
--68.00K
375.00%66.00K
-32.56%29.00K
---24.00K
--43.00K
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-Change in other current liabilities
-46.01%-311.00K
-195.41%-478.00K
425.49%166.00K
22.22%396.00K
-432.81%-213.00K
107.88%501.00K
43.33%-51.00K
150.00%324.00K
-65.96%64.00K
386.90%241.00K
-132.61%-90.00K
33.06%-648.00K
-73.07%188.00K
---84.00K
--276.00K
-226.37%-968.00K
263.85%698.00K
--766.00K
---426.00K
86.95%246.95K
--69.58K
--132.09K
----
----
---40.20K
--89.59K
---35.54K
---81.51K
---22.57K
--14.10K
Cash from non-recurring investing activities
Cash from operating activities
-5.74%-4.27M
-19.64%-5.02M
14.21%-2.71M
-18.96%-2.81M
-41.62%-4.04M
-82.07%-4.20M
5.54%-3.15M
40.49%-2.36M
2.89%-2.85M
44.19%-2.30M
-0.57%-3.34M
-4.91%-3.97M
4.02%-2.94M
---4.13M
---3.32M
-120.31%-3.79M
-66.03%-3.06M
---1.72M
---1.84M
64.06%-722.59K
--354.45K
---2.01M
3.58%-737.71K
-16.29%-625.31K
---1.36M
---1.18M
---765.14K
---537.72K
---955.75K
---879.37K
Investing cash flow
Net cash from continuing investing activities
750.00%51.00K
0.00%5.00K
-90.63%3.00K
266.67%22.00K
-78.57%6.00K
-93.83%5.00K
-58.44%32.00K
-91.67%6.00K
-88.80%28.00K
-19.00%81.00K
-74.16%77.00K
-79.37%72.00K
73.61%250.00K
--100.00K
--298.00K
96.07%349.00K
108.70%144.00K
--178.00K
--69.00K
1206.38%111.91K
--92.11K
--8.57K
-66.02%5.42K
--2.25K
--7.64K
--819.45
--15.94K
--0.00
--0.00
--6.92K
Capital expenditures
750.00%51.00K
0.00%5.00K
-90.63%3.00K
266.67%22.00K
-78.57%6.00K
-93.83%5.00K
-58.44%32.00K
-91.67%6.00K
-88.80%28.00K
-19.00%81.00K
-74.16%77.00K
-79.37%72.00K
73.61%250.00K
--100.00K
--298.00K
96.07%349.00K
108.70%144.00K
--178.00K
--69.00K
1206.38%111.91K
--92.11K
--8.57K
-66.02%5.42K
--2.25K
--7.64K
--819.45
--15.94K
--0.00
--0.00
--6.92K
Net cash flow from disposal of fixed assets
750.00%51.00K
0.00%5.00K
-90.63%3.00K
266.67%22.00K
-78.57%6.00K
-93.83%5.00K
-58.44%32.00K
-91.67%6.00K
-88.80%28.00K
-19.00%81.00K
-74.16%77.00K
-79.37%72.00K
73.61%250.00K
--100.00K
--298.00K
96.07%349.00K
108.70%144.00K
--178.00K
--69.00K
1206.38%111.91K
--92.11K
--8.57K
-66.02%5.42K
--2.25K
--7.64K
--819.45
--15.94K
--0.00
--0.00
--6.92K
Net cash flow from investment products
----
250100.00%5.00M
-697.37%-5.00M
----
-100.19%-1.00K
-100.02%-2.00K
-80.53%837.00K
-153.31%-837.00K
103.49%519.00K
395.27%8.80M
71.93%4.30M
136.71%1.57M
---14.87M
--1.78M
--2.50M
-1349.83%-4.28M
-100.00%0.00
---295.00K
--4.62M
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
----
----
----
---1.00K
--2.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-920.00%-51.00K
71457.14%5.00M
-721.49%-5.00M
97.27%-23.00K
-101.02%-5.00K
-100.08%-7.00K
-80.94%805.00K
-156.28%-843.00K
103.25%491.00K
419.99%8.71M
91.69%4.22M
132.38%1.50M
-10400.00%-15.12M
--1.68M
--2.20M
-878.01%-4.63M
-103.16%-144.00K
---473.00K
--4.55M
-1206.38%-111.91K
---92.11K
---8.57K
66.02%-5.42K
---2.25K
---7.64K
---819.45
---15.94K
--0.00
--0.00
---6.92K
Financing cash flow
Cash flow from continuous financing activities
38.06%3.54M
237.87%3.72M
122.30%7.47M
10.32%2.08M
-9.69%2.56M
1519.12%1.10M
22293.33%3.36M
--1.89M
--2.84M
-99.50%68.00K
--15.00K
----
----
--13.58M
--0.00
-99.98%1.00K
-100.00%0.00
--5.71M
--8.93M
-111.66%-102.21K
--2.12M
--876.30K
--50.45K
-66.41%488.94K
--542.37K
--473.91K
--0.00
--1.46M
--0.00
---35.11K
Net cash flow from debt Issuance/repayment
----
--0.00
---2.00M
--2.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-82.19%-102.21K
---81.56K
---56.10K
----
----
--489.15K
--473.91K
--0.00
---11.83K
--0.00
---35.11K
Net cash flow from common stock issuance/repurchase
38.06%3.54M
237.60%3.72M
173.15%9.18M
-95.50%85.00K
-9.69%2.56M
--1.10M
--3.36M
--1.89M
--2.84M
-100.00%0.00
----
----
----
--13.57M
----
-99.98%1.00K
----
--5.71M
--8.88M
-100.00%0.00
--2.37M
--932.39K
----
----
--0.00
--0.00
--0.00
--1.47M
--0.00
--0.00
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
----
6700.00%68.00K
----
----
----
--1.00K
--0.00
-100.00%0.00
-100.00%0.00
--4.00K
--52.00K
----
--0.00
--0.00
----
----
--53.22K
----
----
----
----
----
Proceeds from issuance of warrants
----
--3.00K
--292.00K
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
---167.67K
----
--50.45K
--488.94K
----
----
--0.00
--0.00
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
38.06%3.54M
237.87%3.72M
122.30%7.47M
10.32%2.08M
-9.69%2.56M
1519.12%1.10M
22293.33%3.36M
--1.89M
--2.84M
-99.50%68.00K
--15.00K
----
----
--13.58M
--0.00
-99.98%1.00K
-100.00%0.00
--5.71M
--8.93M
-111.66%-102.21K
--2.12M
--876.30K
--50.45K
-66.41%488.94K
--542.37K
--473.91K
--0.00
--1.46M
--0.00
---35.11K
Net cash flow
Beginning cash balance
17.62%8.90M
-53.42%4.97M
-44.23%5.38M
-44.92%6.04M
-28.19%7.56M
178.91%10.67M
218.44%9.65M
96.03%10.97M
-55.48%10.53M
-69.24%3.83M
-77.49%3.03M
-74.98%5.59M
-7.66%23.66M
--12.44M
--13.47M
49.18%22.36M
631.61%25.62M
--14.98M
--3.50M
30.50%5.78M
--3.36M
--4.43M
-39.13%2.18M
-17.78%2.27M
--2.31M
--3.11M
--3.57M
--2.76M
--3.61M
--4.70M
Current period cash flow changes
48.69%-782.00K
226.36%3.93M
-140.43%-412.00K
50.00%-657.00K
-451.96%-1.52M
-146.32%-3.11M
28.18%1.02M
48.73%-1.31M
102.40%433.00K
-40.23%6.71M
177.11%795.00K
71.16%-2.56M
-453.12%-18.07M
--11.22M
---1.03M
-344.96%-8.89M
-128.44%-3.27M
--3.63M
--11.48M
19.02%-935.00K
--2.39M
---1.15M
6.86%-712.91K
-114.08%-126.80K
---835.63K
---769.46K
---765.40K
--900.85K
---936.85K
---955.49K
Effect of exchange rate changes
107.14%3.00K
3933.33%230.00K
-2237.50%-171.00K
4500.00%92.00K
2.33%-42.00K
-102.63%-6.00K
107.62%8.00K
102.22%2.00K
-437.50%-43.00K
132.65%228.00K
-223.53%-105.00K
81.13%-90.00K
87.10%-8.00K
--98.00K
--85.00K
-537.61%-477.00K
60.76%-62.00K
--109.00K
---158.00K
114.42%1.71K
--9.70K
---11.88K
-229.08%-20.24K
169.09%11.81K
---8.21K
---65.01K
--15.68K
---17.09K
--18.90K
---34.09K
Ending cash balance
34.35%8.12M
17.62%8.90M
-53.42%4.97M
-44.23%5.38M
-44.92%6.04M
-28.19%7.56M
178.91%10.67M
218.44%9.65M
96.03%10.97M
-55.48%10.53M
-69.24%3.83M
-77.49%3.03M
-74.98%5.59M
--23.66M
--12.44M
-27.64%13.47M
49.18%22.36M
--18.61M
--14.98M
48.39%4.83M
--5.80M
--3.26M
-48.24%1.46M
-41.72%2.14M
--1.46M
--2.30M
--2.81M
--3.67M
--2.68M
--3.71M
Free cash flow
-6.85%-4.32M
-19.62%-5.02M
14.98%-2.71M
-19.59%-2.83M
-40.45%-4.04M
-76.10%-4.20M
6.73%-3.19M
41.40%-2.37M
9.63%-2.88M
43.59%-2.38M
5.58%-3.42M
2.20%-4.04M
0.53%-3.19M
---4.23M
---3.62M
-118.04%-4.13M
-67.57%-3.20M
---1.90M
---1.91M
58.67%-834.50K
--262.35K
---2.02M
4.86%-743.13K
-16.71%-627.56K
---1.37M
---1.18M
---781.08K
---537.72K
---955.75K
---886.29K
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Icecure Medical Ltd Generate?

Icecure Medical Ltd generated -14.57M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Icecure Medical Ltd's Operating Cash Flow Change Year Over Year?

Icecure Medical Ltd's operating cash flow increased by -16.01% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Icecure Medical Ltd Spend on Capital Expenditures?

Icecure Medical Ltd spent 36.00K on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Icecure Medical Ltd's Financing Cash Flow Changed?

Icecure Medical Ltd used 15.83M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ICCM?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Icecure Medical Ltd’s free cash flow in the latest quarter?

Free cash flow was -14.61M reflecting a -15.64% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.